Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia-Basteiro AL, Goletti D, Jankovic M, Kuksa L, Maurer FP, Méchaï F, Tiberi S, van Leth F, Veziris N, Lange C; Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and; Tuberculosis Network European Trials group (TBnet).
Guglielmetti L, et al.
Eur Respir J. 2022 May 19;59(5):2200388. doi: 10.1183/13993003.00388-2022. Print 2022 May.
Eur Respir J. 2022.
PMID: 35589114
Free PMC article.